世界中医药
文章摘要
引用本文:宋恩峰1,张彩蝶1,梅莎莎1,裴学军2,肖飞2.健脾生血颗粒治疗老年人缺铁性贫血临床观察[J].世界中医药,2016,(05):.  
健脾生血颗粒治疗老年人缺铁性贫血临床观察
Clinical Observation on Jianpi Shengxue Granule in the Treatment of Elderly Patients with Iron Deficiency Anemia
投稿时间:2016-03-29  
DOI:10.3969/j.issn.1673-7202.2016.05.015
中文关键词:  健脾生血颗粒  老年人  缺铁性贫血  福乃得
English Keywords:Jianpi Shengxue Keli  Elderly people  Iron deficiency anemia  Fulaide oral liquid
基金项目:武汉市科技攻关计划(编号:2013070204020053)
作者单位
宋恩峰1,张彩蝶1,梅莎莎1,裴学军2,肖飞2 1 武汉大学人民医院中医科武汉430060 2 健民药业集团儿童药物研究院武汉430050 
摘要点击次数: 869
全文下载次数: 1016
中文摘要:
      目的:观察健脾生血颗粒治疗老年人缺铁性贫血的临床疗效及作用机制。方法:将80例符合缺铁性贫血的老年患者随机分为2组。对照组32例,给予福乃得口服治疗。治疗组48例,给予健脾生血颗粒口服。2组连续治疗30 d后观察有效率及RBC、Hb、MCV、MCH、MCHC、血清铁、总铁结合力指标变化。结果:治疗组临床总有效率明显高于对照组(P<0.05)。2组治疗后RBC、Hb、MCV、MCH、MCHC、血清铁、总铁结合力均有显著改善,但2组治疗后指标比较无统计学意义(P>0.05)。结论:健脾生血颗粒治疗老年人缺铁性贫血疗效显著,值得临床推广应用。
English Summary:
      To observe the clinical effect and the mechanism of Jianpi Shengxue Granule in the treatment of elderly patients with iron deficiency anemia. Methods:Eighty elderly patients with iron deficiency anemia who meet with inclusive criteria were selected and randomly divided into two groups, namely the control group (32 patients) with Funaide oral liquid and the treatment group (48 patients) with Jianpi Shengxue Granule. The efficacy was observed after 30 days in two groups. Results:The total effective rate of treatment group was better than that of control group (P<0.05). The RBC, Hb, MCV, MCH, MCHC, serum iron and TIBC were obviously improved after the treatment compared with those before treatment (P<0.05) but without significant difference between the two groups after treatment (P>0.05). Conclusion:Jianpi Shengxue Granule may have good cure effect on iron deficiency anemia in elderly patients and it is worthy of clinical use.
查看全文  查看/发表评论  下载PDF阅读器